Presentation slides

SPMU
Portfolio – People - Practice
(or… what are these LFAs doing anyway?)
4 December 2013
Systems Performance and Monitoring Unit
SPMU
Outline
1. Staff and Countries
2. Expertise and Services
3. The Global Fund
4. Performance-based Funding and Risk
Management / Role of LFAs
4 December 2013
2
Local Fund Agent for 15 countries
65 SPMU staff members worldwide
Switzerland: 20
Palestine: 1
Syria: 1
Niger: 3
Mali: 2
Senegal: 5
The Gambia: 2
Burkina Faso: 4
Ivory Coast: 1
Myanmar: 7
Chad: 2
Djibouti: 2
Laos: 1
Cambodia: 8
Benin: 4
Equatorial
São Tomé
Guinea
& Príncipe
as of 10/2013
4 December 2013
3
SPMU staff
expertise
Public Health,
Programmatic,
Monitoring &
Evaluation
Procurement
& Supply
Management
(PSM)
4 December 2013
Finance
4
SPMU staff
expertise
HQ Basel
Sabine Lützelschwab
Cyrille Dubois
César Wong
Public
Health /
M&E
Laura Hirschi
Luis Segura
Bruno Lab
Susanne Schranz
Francois Crabbé
Alexandra Nicola
Odile Pham-Tan
Raphael Girod
William Lenoir
Christine Perrier
Emanuel Pinheiro
PSM
Finance
Gertrud Koller-Thürck
Jean-Pierre Juif
Messan Ganfled Antoine
Heike Albrecht
Yannick Moreno
4 December 2013
5
Soe Soe Htun
Abdoulkarim Nassirou
Cyrille Dubois
Anni Maganga d’Almeida
Public
Health /
M&E
César Wong
SPMU staff
expertise
worldwide
Ilmi Alwaleh Elabeh
Sandra Fonkui
Ye Mon Myint
Luis Segura
Adrien Nougtara
Jan De Jong
Saihou Ceesay
Silvia Sangaré-Mollet
Mona Alhaj Hussain
Francois Crabbé
Fortuné Capo-Chichi
Josiane Gyengani
Bruno Lab
Odile Pham-Tan
Alexandra Nicola
Félix Mpfizi
Yannick Moreno
Emmanuel Wintz
Dominique Guinot
Saw Heir Soul
Amadou Midou
Abdramane Maiga
Christine Perrier
David Mullany
Pasoli Ibrahim Kanyi
Janet Kimeu
Mauricio Aragno
Gertrud Koller-Thürck
Celine Kuoch
Gaelle Audrey Kouassi
PSM
Air Kaoleap
Pisak Long
Hans Peter Bollinger
Finance
Heike Albrecht
Raphael Girod
Sin Sokunthea
Claude Panou
Sophie Laroche
Mathias Ahiho
Ana Brou Santiago
Prak Davy
Anousorn Dindavong
Bintou Coumba Yelli Fall
Messan Ganfled Antoine
Monique Ouffoue
Olivia de Guzman
Abdoulaye Alhousseini Maiga
Ismail Said Bouh
Ranya Karam
Karin Goschler
Emanuel Pinheiro
4 December 2013
Yin Thwe Thein
William Lenoir
Jean-Pierre Juif
Firas Dali
6
And how it
comes
together in
our work
Public
Health /
M&E
Performancebased Funding
PSM
4 December 2013
Finance
7
The Global Fund to Fight AIDS, TB and Malaria
• Founded in 2002
• The main multilateral funder in global health
• Of all international financing, it channels 82 percent for TB,
50 percent for malaria and 21 percent for AIDS
• Signed funding 2002-2012: USD 23.78 billion
HIV/AIDS: USD 13.2 bn – Malaria: USD 6.8 bn – TB: USD 3.8 bn
• Supports programs in over 140 countries
• Funding per program:
few hundred thousand USD – several hundred million USD
• No in-country presence
4. Dezember 2013
Local Fund Agent
8
Performance-based
Funding
Global Fund
Set-Up
Country
Coordinating
Mechanism
Principal
Recipient
Requests for New/Continued Funding
Reporting of results
Requests for disbursement
Disbursement decisions
Funding
Reporting
SubRecipients
Local Fund
Agent
Management Decisions
Verification of results /
Review of outcome/impact
New funding contracts
Assessment of implementation
& quality of service provision
Global Fund
Secretariat
4 December 2013
Recommendations related to
implementation & service provision
Funding/Disbursement
Recommendation
9
Public Health / Monitoring & Evaluation
Spider-graph
from M&E country
profile
Assessments
of national
M&E structures
and systems
4 December 2013
10
Public Health / Monitoring & Evaluation
Color Code Key
green 2.5 - 3.0 Yes, completely
yellow 1.5 - 2.5
red
< 1.5
Partly
No - not at all
On-Site
Data Quality
Verifications
4 December 2013
11
Public Health / Monitoring & Evaluation
Assessments of
Quality of Services
Is there a quality assurance plan
available at central level for
maintaining diagnostic quality
over time?
Are antimalaria drugs provided
to patients free of charge?
Does the country have national
guidelines/protocols on malaria
treatment available in the facility?
…
4 December 2013
12
Public Health / Monitoring & Evaluation
Targets
cumulative?
Top 10 indicator?
Actual Result
to date
(as reported by PR)
Verification
Method
Current
grant
N-not cumulative
Yes - Top 10
833.00
1,005.00
Desk Review
1,005
120%
Number of testing and counseling services for HIV provided to men who have sex with men (including
transvestites, transgendered, gay and bisexual men) by the mobile unit
Current
grant
Y-cumulative
annually
Yes - Top 10
480.00
503.00
Desk Review
503
105%
Number of cases of sexually transmitted infections diagnosed and treated amongst men who have sex
with men (including transvetites, transgendered, gay and bisexual men)
Current
grant
Y-over program
term
No
1.5
Number of condoms distributed to people
National
Program
Y-over program
term
1,000.00
631.00
Desk Review
631
63%
1
1.6
Percentage of MSM, transvestites, transgendered, gay and bisexual men who both correctly identify the
ways of preventing the sexual transmission of HIV and who reject the major misconceptions about HIV
transmission
Yes - Top 10
2,782,156.00
3,421,520.00
Desk Review
3,421,621
120%
Current
grant
N-not cumulative
Yes - Top 10
0.75
0.98
Desk Review
98%
120%
2
2.1
Number of prevention services provided to commercial sex workers
Current
grant
N-not cumulative
Yes - Top 10
7,176.00
14,060.00
Desk Review
14,060
120%
2
2.4
Number and percentage of pregnant women who were tested for HIV and who know their results
Current
grant
Y-cumulative
annually
Yes - Top 10
0.35
Desk Review
78,059
120%
3
3.2
Number of health care personnel trained in integral care of people living with HIV/AIDS
Current
grant
Y-over program
term
Yes - Top 10
110.00
457.00
Desk Review
457
120%
3
3.3
Number of adults and children currently receiving antiretroviral therapy
GF and
other donors
N-not cumulative
Yes - Top 10
1,800.00
2,036.00
Desk Review
2,036
113%
3
3.4
Percentage of selected health facilities that meet the protocol of TARGA for adults and children
Current
grant
Y-over program
term
No
0.60
0.67
Desk Review
67%
112%
3
3.5
Number and percentage of adults and children enrolled in HIV care who had TB status assessed and
recorded during their last visit among all adults and children enrolled in HIV care
Current
grant
Y-cumulative
annually
Yes - Top 10
0.60
Desk Review
1,918
120%
4
4.1
Number of departmental quarterly reports delivered according to schedule that includes national M&E
indicators
Current
grant
N-not cumulative
No
8.00
8.00
Desk Review
8
100%
4
4.2
Number of operational research studies conducted
Current
grant
N-not cumulative
No
5.00
5.00
Desk Review
5
100%
Objective
No.
Indicator
No.
1
1.1
Number of men who have sex with men (include: transvestites, transgendered, gay and bisexual men)
currently being reached through the peer education promoter strategy
1
1.2
1
1.3
1
Indicator Description
Tied to
Intended Target
to date
(from PF)
77879- 50%
1918-94%
% achievement
Verified Result (Please calculate as
appropriate)
Routine
verifications
4 December 2013
13
Finance: from Budget Summaries…
C. SUMMARY BUDGET BREAKDOWN BY IMPLEMENTING ENTITY
#
PR/SR
1
2
3
4
5
6
7
8
9
10
11
12
13
PR
SR
SR
SR
SR
SR
SR
SR
SR
SR
SR
SR
SR
4 December 2013
Name
Save the Children Federation, Inc
AFXB
AHRN
Alliance
AMI
Burnet
Consortium
International Organization for Migration (IOM)
Malteser
MDM
MSF Holland
MSF Switzerland
Population Service International (PSI)
Year 1
Year 2
1,496,047
295,551
585,457
710,613
433,708
194,342
1,437,274
763,245
162,892
2,245,841
2,314,136
680,608
90,695
11,410,408
1,761,496
331,400
932,023
1,515,305
675,481
348,644
2,212,848
1,025,575
327,329
2,589,369
2,512,037
953,974
1,234,595
16,420,077
Total
Phase 1
3,257,543
626,951
1,517,479
2,225,919
1,109,189
542,985
3,650,122
1,788,820
490,221
4,835,210
4,826,173
1,634,582
1,325,290
27,830,485
14
Cost category
Assumptions
Implementing
Entity Type
0
1.1.1.
Alliance
NGO/CBO/
For sex w orker project; 2 sites
Academic
Training
3
3
3
3
1.1.2
Alliance
NGO/CBO/
Peer educators in 2 sites
Academic
Human Resources
0
864
0
0
0
1.1.3
Alliance
NGO/CBO/
Reprinting of IEC pamphlet
Academic
Communication
Materials
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
150 150 150 150 1.1.4
Alliance
NGO/CBO/
Monthly group sessions
Academic
Training
Referrals for STI and
VCCT
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
90 150 180 180 1.1.5
Alliance
NGO/CBO/ Transportation to SW for referrals
Academic at NGO/public health facilities
Living Support to
Clients/Target
Population
Outreach w orker
monitoring and
evaluation activities
Outreach w orker
monitoring and
evaluation activities
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
BCC - community outreach
and schools
Support for sex
w orkers w ho are sick
1
BCC - community outreach
and schools
1
BCC - community outreach
and schools
BCC - community outreach
and schools
Training on community
outreach and peer
education
1.1.2
1
BCC - community outreach
and schools
Employment of
outreach w orkers
1.1.3
1
BCC - community outreach
and schools
Design and production
of IEC materials
1.1.4
1
BCC - community outreach
and schools
Implement community
outreach and peer
educaiton programme:
group essions
1.1.5
1
BCC - community outreach
and schools
1.1.6
1
BCC - community outreach
and schools
1.1.7
1
BCC - community outreach
and schools
1.1.8
1
1.1.9
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
Q4
Q2
20 0
1
Q3
Q1
0
1.1.1
1.1.10
Directly
related
indicator
Activity
Objective
Reference N.
Timing
Service Delivery
Area (SDA)
Reference to
Previous
Rounds or
Other Source
of Funding
Responsible
for
Implementati
on
…to Detailed Breakdowns… of Budgets
0
0
0
0
1.1.6 (omitted) Alliance
NGO/CBO/ Supervision visits (cost of
Academic motorbikes for management staff)
Monitoring and
Evaluation (M&E)
3
3
3
3
1.1.7
Alliance
NGO/CBO/ Supervision visits (cost of travel)
Academic for management staff
Monitoring and
Evaluation (M&E)
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
6
6
6
6
New
Alliance
NGO/CBO/ Support for sex w orkers w ho are
Academic sick
Living Support to
Clients/Target
Population
Support for sex
w orkers w ho are in jail
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
3
3
3
3
New
Alliance
NGO/CBO/ Support for sex w orkers w ho are
Academic in jail
Living Support to
Clients/Target
Population
Implement community
outreach and peer
educaiton programme:
Transportation for
outreach volunteers
Sex w orkers reached by package of
BCC prevention and STI prevention /
treatment
280 280 280 280 New
Alliance
NGO/CBO/
Transportation of ORW
Academic
Planning and
Administration
Sex w orkers reached by package of
4 December 2013
15
…to Detailed Breakdowns… of Expenditures
5.2.2.1.2 Adec uac ion de infr aes tr uc tur a de un labor ator io par a el diagnos tic o de T B a tr av es de c ultiv o
F ECHA
8/14/2012
Nº DE DO CT O
Nº DE SC
cf-11
sc/sin numero
Nº DE CHEQ UE
BENEF ICIARIO
1801336 industrial equipment, s.a. de c.v.
T O T AL
VALO R
$
8,993.08
$
8,993.08
1.3.5.1.1 Cinc o ( 5) jor nadas de s eguimiento y ev aluac ion de las ac tiv idades de APP y la s oc . c iv il ( 30 per s onas c /u )
F ECHA
Nº DE DO CT O
Nº DE SC
Nº DE CHEQ UE
8/27/2012
8137
0463/S4 Bolpro
1801351
hotesa, s.a. de c.v.
BENEF ICIARIO
$
VALO R
420.00
8/27/2012
7899
0463/S4 Bolpro
1801354
hotesa, s.a. de c.v.
$
378.00
8/9/2012
8007
0463/S4 Bolpro
1801348
hotesa, s.a. de c.v.
$
378.00
8/9/2012
8008
0463/S4 Bolpro
1801345
hotesa, s.a. de c.v.
$
378.00
8/9/2012
7914
0463/S4 Bolpro
1801347
hotesa, s.a. de c.v.
$
378.00
8/17/2012
cf-08639
0463/S4 Bolpro
1801364
hotesa, s.a. de c.v.
$
420.00
8/17/2012
cf-17755
0463/S4 Bolpro
1801363
Inversiones los Ceresos, s.a. de c.v.
$
420.00
8/17/2012
cf-07896
0463/S4 Bolpro
1801371
hotesa, s.a. de c.v.
$
378.00
8/31/2012
cf-17751
0463/S4 Bolpro
1801368
Inversiones los Ceresos, s.a. de c.v.
$
420.00
T O T AL
$
3,570.00
1.3.5.2.1 Contr atac ion de c ons ultor ia que ejec ute inv es tigac ion p/c onoc er la aplic ac de la es tr ategia T AES s /es tandar es inter nac ionales
F ECHA
4 December 2013
Nº DE DO CT O
Nº DE SC
Nº DE CHEQ UE
9/14/2012
38
1124/S4
1801396
Maria de los Angeles Hernandez
BENEF ICIARIO
$
VALO R
3,510.00
11/16/2012
cf-42
1124/S4
1801438
Maria de los Angeles Hernandez
$
3,510.00
9/14/2012
38
1124/S4
1801415
Maria de los Angeles Hernandez RENTA
$
390.00
12/21/2012
43
1124/S4
4101484
Maria de los Angeles Hernandez
$
4,680.00
12/4/2012
cf-43
1124/S4
4101460
Maria de los Angeles Hernandez renta pagado por anticipado
$
520.00
12/4/2012
cf-42
1124/S4
4101460
Maria de los Angeles Hernandez renta
$
390.00
T O T AL
$
13,000.00
16
…to Supporting Documents - if there are any
4 December 2013
17
Procurement & Supply Management
Forecasting/
Quantification
Item
Strength
Area A Area B
stocks stocks
end of
end of
June 2012 June 2012
Total QTY
# of
Expected
expected
Year 4
available # of T abs no . of
tabs/vials
remaining Year 4
per patients in needed to
expected
in Areas
stock at expected
drug
Julytreat
1+2 as o f course/
the end o f patients
needs
end-June patient December expected #
Year 3
2012
2012
of patients
Year 4
needs
incl.
Buffer
50%
2FDC-B (RH)
150/75
12,864
11,340
24,204
480
20
9,600
14,604
RH Pediatric
60/30
3,690
1,230
4,920
360
3
1,080
3,840
6
2,160
3FDC
150/75/275
2,016
1,428
3,444
450
3
1,350
2,094
6
2,700
RHZ Pediatric
60/30/150
1,980
1,296
3,276
450
3
1,350
1,926
6
2,700
4,050
9,782
240
20
4,800
4,982
7,046
5,404
40
9,600
2,668
360
3
1,080
1,588
6
2,160
190
60
3
180
10
6
360
4FDC -B (RHZE) Cat 1 150/75/400/275
4FDC -B (RHZE) Cat 2 150/75/400/275
Streptomycin
1g
100
90
40
19,200
28,800
Year 4
no. of
drug
packs
quantities
needed
needed
14,196
21.13
3,240
3,240
36.00
4,050
4,050
6.03
4,050
45.00
14,400
9,418
14.01
3,240
1,652
2.46
540
540
5.40
Distribution
4 December 2013
Storage
Consumption
18
Procurement & Supply Management
4 December 2013
19
Performance-based Funding
Raise it. The Global Fund
continually raises funds.
Spend it. The money
received from donors is
channeled to program
implementers.
Prove it. The
achievements of grant
activities are measured
against performance
indicators and the results
are used for ongoing
funding decisions.
4 December 2013
Raise
it
Spend
it
Prove
it
20
LFAs and Management of Risks
Institutional assessments of implementing agencies in different
functional areas (M&E, PSM, SR Management, etc.)
⇒ Recommendation of risk mitigation measures prior to grant
signing/grant start to improve systems and close capacity gaps
Continuous verification of implementation
(programmatic achievement against financial activities)
⇒ Recommendation of corrective measures during grant
implementation or more in-depth assessments/verifications
Special reviews and assessments (risk of drug theft, adequacy of
quantifications, procurement reviews, etc.)
⇒ Recommendation of measures to improve specific capacity
gaps/system’s weaknesses, identification of potential fraud
4 December 2013
21
Thank you!
4 December 2013
22
4 December 2013
23
Performance Rating & Funding Decision
Grant Performance Evaluation
4 December 2013
Disbursement decision
24
Progress Update/Disbursement Request (PU/DR)
Programmatic Performance by Indicator
Target
Indicator Name
Result
Period
Value
R_Period
R_Value
Result in %
Nombre de contacts parmi les TS ayant bénéficié d'au moins une
intervention du paquet d'interventions combinées/intégrées de
prévention du VIH et des IST
Q4
6’600
Q4
6’979
106%
Nombre de contacts parmi les détenus ayant bénéficié d'au moins
une intervention du paquet d'interventions combinées/intégrées de
prévention du VIH et des IST
Q4
2’800
Q4
7’030
120%
(capped)
Nombre de contacts parmi les HSH ayant bénéficié d'au moins une
intervention du paquet d'interventions combinées/intégrées de
prévention du VIH et des IST
Q4
895
Q4
706
79%
Nombre de préservatifs féminins distribués au niveau
communautaire aux personnes cibles
Q4
33’333
Q4
9’321
28%
Nombre de personnes conseillées et testées pour le dépistage de
l'infection à VIH par les services communautaires et qui
connaissent les résultats
Q4
47%
Q4
39%
84%
…
…
…
…
…
…
4 December 2013
25
Progess Update/Disbursement Request (PU/DR)
Calculation Table
Quantitative Indicator Rating
ALL indicators rating
Performance Rating
A1
> 100%
Top 10 Indicators Rating
A1
A2
B1
B2
C
A2
100-90%
A1
A1
A1
A2
A2
A2
B1
60-89%
A2
A2
A2
A2
B1
B1
B2
30-59%
B1
A2
B1
B1
B1
B2
C
<30%
B2
B1
B1
B2
B2
B2
AVG performance on Top 10
TRAINING Indicators only
0
C
B2
B2
B2
C
C
AVG performance on TOP TEN
indicators (including TRAINING)
97%
Number of TOP TEN indicators
with B2 or C Rating
0
TOP TEN indicators rating
A2
AVG performance ALL
indicators
56%
Intermediate Quantitative Rating
result from the Matrix above
B1
ALL indicators rating
B2
Intermediary Result for
Quantitative Indicator rating
See Rating highlighted in
the Matrix
Final Quantitative Rating
B1
4 December 2013
26
Progess Update/Disbursement Request (PU/DR)
Section 7: Disbursement Recommendation
A. DISBURSEMENT RECOMMENDATION
Overall Rating
B1
Indicative disbursement ranges by performance rating (included as a reference)
Range for cumulative disbursement amount
(after the currently recommended disbursement)
Performance rating
A1
Exceeding expectations
Above 95% of cumulative budget through the next reporting period
A2
Meeting expectations
Between 85-105% of cumulative budget through the next reporting period
B1
Adequate
Between 55-95% of cumulative budget through the next reporting period
B2
Inadequate but potential demonstrated
Between 25-65% of cumulative budget through the next reporting period
Unacceptable
Below 35% of cumulative budget through the next reporting period
C
1. Cash amount requested by the Principal Recipient from the Global Fund for next disbursement period plus one additional
quarter (amount in: EUR):
12 564 761
2. LFA disbursement recommendation (amount in: EUR):
12 470 957
Cumulative budget
through the next period
of implementation
(including the buffer)
15 239 452
4 December 2013
Cumulative
disbursed amount to
date (*)
Cumulative disbursed
after recommended
disbursement
(including the buffer)
519 258
12 990 215
% range
85%
27